期刊文献+

胸部CT联合血清癌胚抗原、铁蛋白检测对肺癌的诊断价值 被引量:5

Diagnosis of pulmonary carcinoma by chest ct and detection of serumCEA, SF levels
下载PDF
导出
摘要 目的探讨胸部CT和血清铁蛋白、癌胚抗原检测及联合应用诊断肺癌的价值。方法选择肺肿瘤患者73例,均在治疗前行胸部CT检查和检测血清铁蛋白(SF)、癌胚抗原(CEA)两种肿瘤标志物浓度。分别计算两种方法单独及联合诊断肺癌的灵敏度、特异度、诊断正确率、阳性似然比和阴性似然比,并加以比较分析。结果二法联合检测与二法单独检测相比灵敏度、诊断正确率最高,阴性似然比最低。结论胸部CT和SF、CEA检测在肺癌诊断中具有较高价值,二者联合应用诊断肺癌具有互补作用。 Objective To investigate the value of chest CT and detection of serum CEA, SF in diagnosis of pulmonary carcinoma. Methods Chest CT were performed and serum levels of CYFRA21-1 and NSE were measured with R IA in 73 patients with pulmonary nodules, the sensitivity , specificity, efficiency, positive likelihood ratio and negative likelihood ratio of two methods for diagnosis of cancer were compared. Results Combined determinations have the highest sensitivity, efficiency and the lowest negative likelihood ratio. Conclusion Both of chest CT and detection of serum CEA and SF are important methods in diagnosis of pulmonary carcinoma and they are complementary to each other.
作者 何东凌 冯青
出处 《国际医药卫生导报》 2008年第20期77-79,共3页 International Medicine and Health Guidance News
关键词 血清癌胚抗原 铁蛋白质 CT 肺癌 CEA SF CT Pulmonary carcinoma
  • 相关文献

参考文献5

二级参考文献28

  • 1Pollan M, Varela G, Torres A, et al. Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse,metastasis and death in resectable non-small cell lung cancer. Int J Cancer, 2003,107 ;781 - 790.
  • 2Ferrigno D, Buccheri G, Giordano C. Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC). Lung Cancer, 2003,41 : 311-320.
  • 3Cambell T, Skillton R A, Coombes R C, et al. Isolation of a lactoferrin cDNA clone and its expression in human breast cancer. Br J Cancer, 1992,65:19-26.
  • 4Gaspar M J, Diez M, Rodriguez A, et al. Clinical value of CEA and CA125 regarding relapse and metasta-sis in resectable non-small cell lung cancer. Antlcancer Res,2003,23 : 3427-3432.
  • 5Alatas F, Alatas O, Metintas M, et al. Diagnostic value of CEA, CA15-3,CA19-9,CYFRA21-1 and TSA assay in pleural effusions. Lung Cancer, 2001,31:9-16.
  • 6Light RW. Clinical manifestations and useful tests. In: Light RW. Pleural diseases.3rd ed.Baltimore: Williams and Wilkins,1995.36-74.
  • 7Villena V, Encuentra Al, Sustaeta JE, et al. Diagnostic value of CA72-4,CA15-3, and CA19-9 assay in pleural fluid: a study of 207 patients. Cancer, 1996, 78:736-740.
  • 8Ebert W, Muley T. CYFRA21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy. Anticancer Res, 1999, 19:2669-2672.
  • 9Osborn M, Weber K, Intermediate filaments: cell-type-specific markers in differentiation and pathology[J]. Cell,1982,31(2 pt 1):303-306.
  • 10Seemann MD, Seemann O, Diemann H, et al. Diagnostic value of chest radiography,comuted tomography and tumor markers in the differentiation of malignant from benign solitary ulmonary lesions[J]. Eur J Med Res,1999,4(8):313-327.

共引文献46

同被引文献42

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部